Stem Cell Therapy and Maculopathy

pic11The macula is responsible for central vision, is an oval-shaped highly pigmented yellow spot near the center of the retina of the human eye. It has a diameter of around 5 mm and is often histologically defined as having two or more layers of ganglion cells. Because the macula is yellow in color it absorbs excess blue and ultraviolet light that enter the eye, and acts as a natural sunblock or sunglasses for this area of the retina. Structures in the macula are specialized for high acuity vision.

Damage to the macula will result in loss of central vision, the progressive destruction of the macula is a disease known as macular degeneration and can sometimes lead to the creation of a macular hole. Macular holes are rarely caused by trauma, but if a severe blow is delivered it can burst the blood vessels going to the macula, destroying it. A maculopathy is any pathological condition of the macula.

Are you living with Maculopathy? Call us today for a FREE consultation or fill out the Case Evaluation Form to begin.

ProgenCell’s procedures are scientifically designed and professionally followed; we have one goal in mind: substantial health improvement of people with simple logistics.

We do not suggest that patients substitute their current medical doctor or abandon current treatments. Since this is a long-term protocol, is necessary that your current medical doctor continues to follow up on your case.

Step 1:

Information: Our medical experts study your case, your current condition as well as your health history. After a full evaluation it is decided if you could be eligible to participate in this protocol, and receive cell therapy. A multidisciplinary medical committee studies your case and honestly considers your improvement potential.

After your case is evaluated, a ProgenCell staff member will contact you regarding your particular case and potential benefits. We also answer any question you may have about the procedure or the requirements to make it happen.

Step 2:

Plan: Once you have consented, we can plan ahead. Because of ProgenCell’s high demand, it is necessary to schedule a date for your procedure at least 2 to 3 weeks in advance. Exceptions can be made when the condition of the patient requires urgent care.

Step 3:

Conditioning and medical procedure: When your appointment is scheduled, we will assign you an agent that will become your personal assistant related to your medical procedure. This assistant will be able to help you with administrative tasks, logistics, planning your stay, communication with the medical staff, etc. Your personal agent will provide you the proper documentation to complete your medical records and will explain the informed consent. In short, we will coordinate all that’s necessary for a practical and easy stay with ProgenCell. The complete treatment – from beginning to end- will take from 3 to 6 hours, depending on the case. During your recovery time you will have access to a telephone, TV and internet.

Call us today for a FREE consultation or fill out the Case Evaluation Form to begin.

Age-Related Macular Degeneration is a degenerative maculopathy associated with progressive sight loss. It is characterized by changes in pigmentation in the Retinal . Usually affects older adults mad results in a loss of vision in the center of the visual field because of damage to the retina. Macular degeneration can advance to legal blindness and inability to drive, can make it difficult or impossible to read or recognize faces, although enough peripheral vision remains to allow other activities of daily life. The inner layer of the eye is the retina, which contains nerves that communicate sight; behind the retina is the choroid, which contains the blood supply to the macula.

The dry macular degeneration form, begins with characteristic yellow deposits in the macula, cellular debris called drusen, they accumulate between the retina and the choroid, and the retina can become detached or results from atrophy to the retinal pigment epithelial layer below the retina, which causes vision loss through loss of photoreceptors (rods and cones) in the central part of the eye.

In the wet form, which is more severe, blood vessels grow up from the choroid behind the retina, and the retina can also become detached. Causes vision loss due to abnormal blood vessel growth, ultimately leading to blood and protein leakage below the macula. Bleeding, leaking, and scarring from these blood vessels eventually cause irreversible damage to the photoreceptors and rapid vision loss if left untreated.

ProgenCell treatment
No medical or surgical treatment is available for dry AMD. No effective treatments were known for wet macular degeneration either, however, new drugs, like anti-Vascular Endothelial Growth Factor agents, may stop and sometimes reverse the growth of the abnormal blood vessels and improvement of vision when injected directly into the vitreous humor of the eye. The injections can be painful and frequently have to be repeated on a monthly or bi-monthly basis. Consuming omega-3 fatty acids (DHA & EPA) has been correlated with a reduced progression of early ARMD.

In recent times, research have found stem cells to be useful for ophthalmologic conditions including Maculopathy. ProgenCell´s Stem cell treatment for this condition, consist on elevating the number of fresh non manipulated stem cells in the peripheral blood and behind the eye globe, in the retrobulbar cavity. These re-injected stem cells have the potential to duplicate and transform into new cells; they will be absorbed by the back of the eye, engraft in the area, and rebuild macular and retinal tissues as well as repair and create blood vessels, they will also reinforce the neurological system, rejuvenating and replacing damaged cells in the optic nerve. On a surgery room, a bone marrow extraction from the hipbone or tibia bone is performed under local anesthesia (there is no pain). Once completed, the doctor will activate the stem cells with a proprietary technique and as soon as possible they will be infused with a non-invasive IV procedure. ProgenCell performs also a retrobulbar injection to place stem cells behind the eye globe for efficient regeneration of damaged tissue. A small sample of the solution is send to a certified lab where the quantity and quality of the stem cells are verified and studied.

Expected outcome of ProgenCell treatment
The purpose of the therapy is to repair damaged macular and retinal tissue, restore vascularity behind the eye improving its function. Therefore the expected result are stopping or slowing the progress of the illness and ultimate regeneration of the damaged cells to reverse the effects and increase vision . The stem cells travel all over the body and the eye engrafting on damaged tissue improving organ function and neurological connections. Patients have reported in common that they improved their eyesight they also report improving their hearing condition and their energy level.

* All Testimonials are from real patients. The results shown are typical but not guaranteed. The outcome of the treatment is uncertain and depends on each patient condition. The testimonials displayed (text, audio and/or video) are given verbatim except for correction of grammatical or typing errors. Some have been shortened. In other words, not the whole message received by the testimonial writer is displayed, when it seemed lengthy or not the whole testimonial seemed relevant for the general public.